Back to Journals » Vascular Health and Risk Management » Call For Papers
Vascular Health and Risk Management
ISSN: 1178-2048
The following Article Collection/ Thematic Series is currently open for submissions:
Cardio-Ankle Vascular Index
Dove Medical Press is pleased to invite you to submit your work to an upcoming Thematic Series on “Cardio-Ankle Vascular Index” guest edited by Dr. Kohji Shirai in Vascular Health and Risk Management.
When submitting your work, please use the promo code ZLHAK to indicate that your manuscript should be considered for the Thematic Series on “Cardio-Ankle Vascular Index”. This code will also provide you with a 20% discount on the advertised article processing charge. The deadline for submission of manuscripts is 30th of June 2023.
For any enquiries, please email to Jenni Shackleton, Commissioning Editor, at [email protected]
About the Thematic Series
The cardio-ankle vascular index (CAVI) is a new index of the overall stiffness of the artery from the origin of the aorta to the ankle. CAVI is a key tool for the improvement of preventative medicine as this index can estimate the risk of atherosclerosis.
A significant feature of CAVI is that it is entirely independent of blood pressure at the time of measurement. CAVI has been proven to be negatively influenced by many arteriosclerotic diseases, such as coronary artery disease, carotid arteriosclerosis, chronic kidney disease and cerebrovascular disease and many coronary risk factors, such as hypertension, diabetes mellitus, dyslipidemia and smoking. Conversely, CAVI can be positively influenced by lifestyle modifications such as smoking cessation.
Recently, it has been reported that CAVI and several left ventricular functions are co-related, suggesting a connection between the heart muscle and vascular function.
This special CAVI issue of Vascular Health and Risk Management serves to highlight the current and future potential of this index.
Call For Papers

Editor-in-Chief: Professor Roland Asmar
To see where Vascular Health and Risk Management is indexed online view the Journal Metrics
What is the advantage to you of publishing in Vascular Health and Risk Management?
- It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
- Although Vascular Health and Risk Management receives a large number of papers, unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
- The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Vascular Health and Risk Management has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
- Many authors have found that our peer reviewer’s comments substantially add to their final papers.
To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.
PubMed Central and MedLine
Vascular Health and Risk Management is indexed on PubMed Central and MedLine (title abbreviation: Vasc Health Risk Manag). All published papers in this journal are submitted to PubMed for indexing straight away.
Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.
Yours sincerely
Professor Roland Asmar
Editor-in-Chief
Vascular Health and Risk Management
Email: Editor-in-Chief
Related journals you may also be interested in:
- Adolescent Health, Medicine and Therapeutics
- Blood and Lymphatic Cancer: Targets and Therapy
- Clinical Audit
- Clinical Epidemiology
- ClinicoEconomics and Outcomes Research
- Core Evidence
- Diabetes, Metabolic Syndrome and Obesity
- Drug, Healthcare and Patient Safety
- Integrated Blood Pressure Control
- International Journal of Clinical Transfusion Medicine
- International Journal of Nephrology and Renovascular Disease
- International Journal of Wine Research
- Journal of Blood Medicine
- Journal of Vascular Diagnostics and Interventions
- Nutrition and Dietary Supplements
- Open Access Journal of Sports Medicine
- Patient Preference and Adherence
- Patient Related Outcome Measures
- Pharmacogenomics and Personalized Medicine
- Pragmatic and Observational Research
- Psychology Research and Behavior Management
- Research Reports in Clinical Cardiology
- Risk Management and Healthcare Policy
- Therapeutics and Clinical Risk Management